Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Céline Dorival

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of Viral Hepatitis|July 6, 2019
Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategyCharlotte Pronier, Hélène Fontaine, Céline Dorival, et al.
Journal of Viral Hepatitis|August 7, 2019
The dynamic effect of direct-acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis CClovis Lusivika-Nzinga, Hélène Fontaine, Céline Dorival, et al.
Experimental Hematology|December 13, 2006
Short exposure to Notch ligand Delta-4 is sufficient to induce T-cell differentiation program and to increase the T cell potential of primary human CD34+ cellsNathalie Lefort, Clarisse Benne, Jean Daniel Lelièvre, et al.
Pharmacoepidemiology and Drug Safety|May 12, 2018
Signal detection on a patient cohort: A disproportionality analysis of the ANRS CO22 HEPATHER cohort to identify associations between direct acting antivirals and adverse events in patients with hepatitis C virus chronic infectionSarah F Feldman, Nathanaël Lapidus, Céline Dorival, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 2, 2021
Social vulnerability of patients co-infected with hepatitis B and hepatitis delta viruses: Data from the ANRS CO22 HEPATHER cohortFabienne Marcellin, Fabrice Carrat, Clémence Ramier, et al.
Molecular Immunology|April 25, 2006
CD4 regulation in human lymphoid non-T-cells: a role for the silencer elementEnguerran Mouly, Céline Dorival, Françoise Pflumio, et al.
Journal of Viral Hepatitis|December 18, 2022
Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the ANRS CO22 HEPATHER cohortLaurent Lam, Hélène Fontaine, Nathanael Lapidus, et al.
BMC Medical Research Methodology|December 1, 2025
Dealing with differential misclassification of an outcome or a covariate in association studies with an internally validated sample selected not at randomJúlia Lacombe Ossó, Benjamin Glemain, Céline Dorival, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 6, 2022
Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort)Tangui Barré, Hélène Fontaine, Clémence Ramier, et al.
Virology|June 17, 2008
HIV-1 Nef protein expression in human CD34+ progenitors impairs the differentiation of an early T/NK cell precursorCéline Dorival, Fanny Brizzi, Jean-Daniel Lelièvre, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of Viral Hepatitis|July 6, 2019
Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategyCharlotte Pronier, Hélène Fontaine, Céline Dorival, et al.
Journal of Viral Hepatitis|August 7, 2019
The dynamic effect of direct-acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis CClovis Lusivika-Nzinga, Hélène Fontaine, Céline Dorival, et al.
Experimental Hematology|December 13, 2006
Short exposure to Notch ligand Delta-4 is sufficient to induce T-cell differentiation program and to increase the T cell potential of primary human CD34+ cellsNathalie Lefort, Clarisse Benne, Jean Daniel Lelièvre, et al.
Pharmacoepidemiology and Drug Safety|May 12, 2018
Signal detection on a patient cohort: A disproportionality analysis of the ANRS CO22 HEPATHER cohort to identify associations between direct acting antivirals and adverse events in patients with hepatitis C virus chronic infectionSarah F Feldman, Nathanaël Lapidus, Céline Dorival, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 2, 2021
Social vulnerability of patients co-infected with hepatitis B and hepatitis delta viruses: Data from the ANRS CO22 HEPATHER cohortFabienne Marcellin, Fabrice Carrat, Clémence Ramier, et al.
Molecular Immunology|April 25, 2006
CD4 regulation in human lymphoid non-T-cells: a role for the silencer elementEnguerran Mouly, Céline Dorival, Françoise Pflumio, et al.
Journal of Viral Hepatitis|December 18, 2022
Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the ANRS CO22 HEPATHER cohortLaurent Lam, Hélène Fontaine, Nathanael Lapidus, et al.
BMC Medical Research Methodology|December 1, 2025
Dealing with differential misclassification of an outcome or a covariate in association studies with an internally validated sample selected not at randomJúlia Lacombe Ossó, Benjamin Glemain, Céline Dorival, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 6, 2022
Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort)Tangui Barré, Hélène Fontaine, Clémence Ramier, et al.
Virology|June 17, 2008
HIV-1 Nef protein expression in human CD34+ progenitors impairs the differentiation of an early T/NK cell precursorCéline Dorival, Fanny Brizzi, Jean-Daniel Lelièvre, et al.
Pageof 5